Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling Activity
Insider Ownership Percentage: 14.80%
Syros Pharmaceuticals (NASDAQ SYRS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/9/2019 | Srinivas Akkaraju | Director | Buy | 533,332 | $7.50 | $3,999,990.00 | |  |
| 3/14/2019 | Venture Fund Vii L.P. Arch | Major Shareholder | Sell | 167,503 | $7.83 | $1,311,548.49 | | |
| 3/11/2019 | Venture Fund Vii L.P. Arch | Major Shareholder | Sell | 164,583 | $6.80 | $1,119,164.40 | | |
| 1/31/2018 | Srinivas Akkaraju | Director | Buy | 209,424 | $9.55 | $1,999,999.20 | | |
| 12/15/2017 | Jeremy P Springhorn | Insider | Buy | 15,000 | $9.08 | $136,200.00 | | |
| 12/14/2017 | Srinivas Akkaraju | Director | Buy | 109,774 | $9.03 | $991,259.22 | | |
| 10/23/2017 | Colleen Elizabeth Desimone | Insider | Sell | 550 | $16.06 | $8,833.00 | | |
| 8/14/2017 | Richard A Young | Director | Sell | 3,282 | $22.00 | $72,204.00 | 420,101 | |
| 8/7/2017 | Eric R Olson | Insider | Sell | 2,500 | $23.59 | $58,975.00 | 2,500 | |
| 7/25/2017 | Eric R Olson | Insider | Sell | 12,500 | $21.85 | $273,125.00 | 12,500 | |
| 7/25/2017 | Richard A Young | Director | Sell | 3,282 | $22.09 | $72,499.38 | 423,383 | |
| 7/6/2016 | Redmile Group, Llc | Major Shareholder | Buy | 432,746 | $12.50 | $5,409,325.00 | | |
| 7/6/2016 | Robert Nelsen | Director | Buy | 400,000 | $12.50 | $5,000,000.00 | | |
(Data available from 1/1/2013 forward)
